Graston/IASTM

Small positive effects for tendinopathy; not superior to other manual techniques when controlled.

Applicable to soft tissue and musculoskeletal caseloads; usable in outpatient ortho and sports settings.

Billed under manual therapy codes; no Graston-specific billing premium over standard manual therapy.

1-2 day GTOM course; ~$500-800 plus tool purchase; moderately accessible.

Widely adopted technique; moderate employer demand in outpatient PT and sports medicine.

Novel technique can enhance perceived treatment intensity.

Patients will pay cash for hands-on soft-tissue work, especially in sports/ortho settings. Tool-based delivery feels tangible and 'premium' to consumers.

Supports modest upcharges but Graston is widely held and increasingly commoditized by competing IASTM brands (HawkGrips, RockBlades).

Too common among ortho/sports PTs to be a true differentiator anymore; expected baseline rather than standout.

Protocol-based and trainable; other clinicians in a practice can deliver it, which is good for scaling beyond the owner.

Decent consumer recognition via athletes/social media, though most patients don't seek it by name.

Short weekend course, relatively cheap, immediate clinic application; high ROI on time.

Commercial brand cert with minimal weight in faculty hiring or promotion files.

Some studies exist but quality is mixed and largely industry-adjacent; not a scholarship engine.

Can be mentioned in musculoskeletal modules but most DPT programs treat IASTM as one option among many.

Evidence is equivocal; small RCTs, modest effects, debated mechanism vs sham.

Rarely listed as preferred in academic job postings.

Cheap and quick, but the academic payoff is small so efficiency is moderate at best.